original articlessupportive careEfficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
supportive care
Under a Creative Commons license
open access
Key words
neurokinin-1 receptor antagonist
NEPA
netupitant
palonosetron
CINV
highly emetogenic
Cited by (0)
Copyright © 2014 THE AUTHORS. Published by Elsevier Ltd.